04/29/2025
11:46 AM | Hensley Mark Earl (Reporting)
Heron Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/29/2025
11:47 AM | Hensley Mark Earl (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2025
8:57 AM | Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2025
9:08 AM | Forbes William P (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2025
8:39 AM | Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
4:48 PM | Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
6:45 AM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
6:45 AM | Heron Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/20/2025
12:51 PM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
4:40 PM | Heron Therapeutics (Issuer)
Kaseta Michael (Reporting)
| Form 4/A | |
02/04/2025
4:23 PM | Christian Waage (Reporting)
Heron Therapeutics (Issuer)
| Form 4/A | |
Get the Latest News and Ratings for HRTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Heron Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/04/2025
4:27 PM | Heron Therapeutics (Issuer)
Rodriguez Susan (Reporting)
| Form 4/A | |
02/04/2025
4:30 PM | Heron Therapeutics (Issuer)
Johnson Craig A (Reporting)
| Form 4/A | |
02/04/2025
4:34 PM | Dissanaike Sharmila (Reporting)
Heron Therapeutics (Issuer)
| Form 4/A | |
02/04/2025
4:37 PM | Heron Therapeutics (Issuer)
Morgan Adam (Reporting)
| Form 4/A | |
02/04/2025
11:43 AM | Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
11:44 AM | Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
11:44 AM | Forbes William P (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
10:58 AM | Heron Therapeutics (Issuer)
Kaseta Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
10:48 AM | Dissanaike Sharmila (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
10:41 AM | Heron Therapeutics (Issuer)
Johnson Craig A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
10:32 AM | Christian Waage (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
10:33 AM | Heron Therapeutics (Issuer)
Rodriguez Susan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
8:17 AM | Heron Therapeutics (Issuer)
Morgan Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
8:32 AM | Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
8:15 AM | Forbes William P (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
8:06 AM | Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:05 PM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
4:15 PM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
8:32 AM | Adage Capital Management, L.P. (Filed by)
Heron Therapeutics (Subject)
| Form SC 13G | |
11/06/2024
1:08 PM | Heron Therapeutics (Issuer)
Kaseta Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
11:41 AM | Heron Therapeutics (Issuer)
Kaseta Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/04/2024
4:09 PM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
1:02 PM | BlackRock, Inc. (Filed by)
Heron Therapeutics (Subject)
| Form SC 13G | |
10/21/2024
2:49 PM | Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/21/2024
2:53 PM | Forbes William P (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:35 PM | Heron Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/22/2024
8:44 AM | Forbes William P (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
8:54 AM | Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
8:32 AM | Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:44 AM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Virtually Limitless Energy? (Ad) A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discovered a new form of power—what some are calling “Helios” technology. It’s not solar, wind, or even nuclear fission. In fact, it could yield more energy than oil, gas, and coal combined—without harmful byproducts.
This obscure company could be at the center of the next trillion-dollar energy revolution. One company’s discovery could change power forever |
06/18/2024
3:43 PM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
1:21 PM | Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
8:34 AM | Forbes William P (Reporting)
Heron Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
10:08 AM | Heron Therapeutics (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
05/29/2024
7:05 AM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
7:05 AM | Heron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
7:05 AM | Heron Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Buy HRTX Stock Free HRTX Stock Alerts